[Effects of salbutamo and ipraopium bromide inhalation on pulmonary function in young children with asthmatoid

Related Experiment Video

Updated: Aug 6, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Wen-Hui Jiang1, Li Deng, Hui-Hong Wen

  • 1Guangzhou Children's Hospital, Guangzhou 510120, China. drjiangwenhui@163.com

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|August 23, 2006
PubMed

Insights

Bronchodilators like salbutamol and ipratropium bromide did not improve lung function in young children with asthmatoid bronchitis. Their effectiveness in treating this condition is questionable, warranting further investigation.

Area of Science:

  • Pediatric Respiratory Medicine
  • Pharmacology
  • Pulmonary Physiology

Context:

  • Asthmatoid bronchitis is a common respiratory condition in young children.
  • The use of bronchodilators in managing asthmatoid bronchitis is debated.
  • Objective assessment of bronchodilator efficacy is crucial for treatment guidelines.

Purpose:

  • To evaluate the impact of salbutamol and ipratropium bromide on pulmonary function in children with asthmatoid bronchitis.
  • To determine if bronchodilator therapy improves airway resistance and ventilation in this pediatric population.

Summary:

  • Pulmonary function tests, including tidal breathing flow volume loops and various flow indexes, were conducted on 20 children before and after bronchodilator inhalation.
  • No significant improvements in airway resistance or ventilation parameters were observed post-inhalation.
  • Key indexes such as peak tidal expiratory flow and tidal volume per kilogram remained unchanged, indicating a lack of therapeutic benefit.

Impact:

  • Findings suggest that standard bronchodilators may not be effective for asthmatoid bronchitis in young children.
  • Challenges the current therapeutic approach and highlights the need for alternative or refined treatment strategies.
  • Underscores the importance of evidence-based medicine in pediatric respiratory care.
Abstract

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...